A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

BACKGROUND: Heart failure (HF) is the final stage of various cardiac diseases with poor prognosis. The integrated traditional Chinese medicine (TCM) and western medicine therapy has been considered as a prospective therapeutic strategy for chronic heart failure (CHF). There have been small clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lijun, Yuan, Hui, Zhang, Dawu, Zhang, Jian, Hua, Qi, Ma, Xiaochang, Chen, Keji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249903/
https://www.ncbi.nlm.nih.gov/pubmed/32481305
http://dx.doi.org/10.1097/MD.0000000000020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249903/
https://www.ncbi.nlm.nih.gov/pubmed/32481305
http://dx.doi.org/10.1097/MD.0000000000020271

Ejemplares similares